Clearstead Advisors, LLC Guardant Health, Inc. Transaction History
Clearstead Advisors, LLC
- $6.31 Billion
- Q3 2024
A detailed history of Clearstead Advisors, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 75 shares of GH stock, worth $2,753. This represents 0.0% of its overall portfolio holdings.
Number of Shares
75
Previous 75
-0.0%
Holding current value
$2,753
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GH
# of Institutions
323Shares Held
127MCall Options Held
844KPut Options Held
2.38M-
Vanguard Group Inc Valley Forge, PA11.7MShares$430 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$413 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA10.1MShares$372 Million0.04% of portfolio
-
Cadian Capital Management, LP New York, NY6.93MShares$254 Million8.13% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$220 Million5.07% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.75B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...